ReviR Therapeutics
ReviR Therapeutics is a biotech company. It has raised $30.0M across 1 round, most recently a $30.0M Series A in July 2024.
- Website
- revirtx.com
- Total Funding
- $30.0M
- Last Round
- $30.0M Series AJul 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.
About
It has raised $30.0M in total across 1 round, most recently a $30.0M Series A round in Jul 2024. Investors include Lapam Capital, CDH Investments and 5Y Capital.
Funding History
Jul 2024
Investors
Similar Companies
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/revir-therapeutics"><img src="https://indexed.vc/api/badge/company/revir-therapeutics" alt="ReviR Therapeutics on Indexed.vc" width="260" height="76" /></a>